Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia
Clinical trial NCT05727761 · RECRUITING
Trial details
- NCT number
- NCT05727761
- Sponsor
- University of Minnesota
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-01
- Primary completion
- 2027-07-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.